Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers in Aortic Stenosis, Hypertrophic Cardiomyopathy, Mitral Regurgitation, Aortic Regurgitation, Prosthetic Heart Valve Dysfunction, and Tricuspid Regurgitation From Pacemaker Leads Study

NCT01334801 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01334801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01334801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers in Aortic Stenosis, Hypertrophic Cardiomyopathy, Mitral Regurgitation, Aortic Regurgitation, Prosthetic Heart Valve Dysfunction, and Tricuspid Regurgitation From Pacemaker Leads Study
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
July 31, 2010
Completion date
January 31, 2020
Enrollment
378 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, aortic valve insufficiency, disorder of prosthetic cardiac valve, hypertrophic cardiomyopathy, mitral valve insufficiency, tricuspid valve insufficiency